Table of Contents x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-33414 ...

InfuSystem Holdings, Inc. (NYSE:INFU) Q3 2023 Earnings Conference Call November 7, 2023 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President & Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Market Alex Nowak - Craig-Hallum Jim Sidoti - Sidoti & Company Operator Good day and welcome to the InfuSystem Holdings Inc. reports Third Quarter 2023 Financial Res ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-3341405 (S ...

InfuSystem Holdings, Inc. (NYSE:INFU) Q2 2023 Earnings Conference Call August 3, 2023 9:00 AM ET Company Participants Joe Dorame - Managing Partner Richard DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Operator Hello, and welcome to the InfuSystem Holdings, Inc. Second Quarter 2023 Fina ...

for the quarterly period ended March 31, 2023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (I.R.S. Employer Identification No.) 3851 West Hamlin Road Rochester Hills, Michigan 48309 (Address of Principal Executive Offices) Registrant's Telephone Number, including Area Code: (248) 291-1210 | Securities Registered Pursuant to Section 12(b) of the Act: | | | | --- | - ...

InfuSystem Holdings Inc. (NYSE:INFU) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Richard DiIorio - CEO Barry Steele - CFO Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alexander Nowak - Craig-Hallum Capital Group James Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings Inc. First Quarter 2023 Financial Results Conference Call. ...

InfuSystem Holdings Inc. (NYSE:INFU) Q4 2022 Earnings Conference Call March 15, 2023 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Richard DiIorio - CEO Barry Steele - CFO Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group James Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Res ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C., 20549 FORM 10-K _____________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ___________________ Commission File Number: 001-35020 ______________________ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2022 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-33414 ...

InfuSystem Holdings Inc. (NYSE:INFU) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Rich DiIorio - CEO Barry Steele - CFO Cary Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Aaron Warwick - Breakout Investors Operator Good day, and welcome to the InfuSystem Holdings, Inc. Reports Third Quarter Fisc ...